References
- Feldman SR, Mellen BG, Housman TS, et al. Efficacy of the 308-nm excimer laser for treatment of psoriasis: results of a multicenter study. J Am Acad Dermatol. 2002;46:900–6
- Hong J, Malick F, Sivanesan P, Koo J. Expanding the use of the 308nm excimer laser for the treatment of psoriasis. Pract Dermatol (Suppl). 2007;S13–16
- Trehan M, Taylor CR. Medium-dose 308-nm excimer laser for the treatment of psoriasis. J Am Acad Dermatol. 2002;47:701–8
- Gattu S, Pang ML, Pugashetti R, et al. Pilot evaluation of supra-erythemogenic phototherapy with excimer laser in the treatment of patients with moderate to severe plaque psoriasis. J Dermatolog Treatment. 2010;21:54–60
- Asawanonda P, Anderson RR, Chang Y, Taylor CR. 308-nm excimer laser for the treatment of psoriasis: a dose-response study. Arch Dermatol. 2000;136:619–24
- Kagen M, Cao LY, Oyetakin-White P, et al. Single administration of lesion-limited high-dose (TURBO) ultraviolet B using the excimer laser: clinical clearing in association with apoptosis of epidermal and dermal T cell subsets in psoriasis. Photodermatol Photoimmunol Photomed. 2012;28:293–8
- Trehan M, Taylor CR. High-dose 308-nm excimer laser for the treatment of psoriasis. J Am Acad Dermatol. 2002;46:732–7
- Sanchez Rodriguez R, Pauli ML, Neuhause IM, et al. Memory regulatory T cells are a unique population resident in human skin. J Clin Invest. In Press
- Carrascosa JM, Tapia G, Bielsa I, et al. Effects of narrowband UV-B on pharmacodynamic markers of response to therapy: an immunohistochemical study over sequential samples. J Cutaneous Pathol. 2007;34:769–76
- Goettsch W, Hurks HM, Garssen J, et al. Comparative immunotoxicology of ultraviolet B exposure I. Effects of in vitro and in situ ultraviolet B exposure on the functional activity and morphology of Langerhans cells in the skin of different species. BritJ Dermatol. 1998;139:230–8